Stomach Neoplasm
58
12
15
19
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.2%
3 terminated out of 58 trials
86.4%
-0.1% vs benchmark
9%
5 trials in Phase 3/4
11%
2 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (58)
Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer
PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy
Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer
[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer
A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer
Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.
Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal Cancer
Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Validation of a Molecular Test for Risk-stratification of Patients With High-risk Intestinal Metaplasia (GCEP2 Study)
Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
Use of Pyrvinium to Reverse Stomach Precancerous Conditions
Rehabilitation and Recovery for Persons with Esophageal or Gastric Cancer
Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable Factor
Finding ED90 of Flumazenil for Selective Improvement of Respiratory Distress by Remimazolam
Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients
Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.
Multimodal Prehabilitation for Resectable Gastric Cancer